are glp 1 drugs fda approved Market Overview: GLP-1 Agonists and the Obesity Market | Blog Lilly is now pharma's top
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Seino Y, Fukushima M, Yabe D
The global market hit over $53 billion in 2024, and depending on which analyst report youre reading, projections suggest we could be looking at $165 billion by the early 2030s
Driessen JHM, van Onzenoort HAW, Henry RMA, Lalmohamed A, van den Bergh JP, Neef C, et al
The FDA and EMA approvals of ZepBound in late 2023 and early 2024 (for weight management) were major regulatory milestones achieved by Lilly ahead of many competitors
